CPT code 19086 denotes an MR-guided percutaneous breast biopsy performed for each additional separately reportable lesion after the first; placement of a localization device may be done at the same time. This code matters nationally because MR-guided breast biopsy is a specialized image-guided service used when lesions are occult on mammography or ultrasound and require high-resolution MR targeting. Accurate coding affects site-of-service reporting, utilization tracking, and payment for complex breast imaging procedures.

Key payers addressed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of clinical context for MR-guided breast biopsy, common payment and coding considerations, and typical sites where the service is delivered. The publication summarizes how 19086 is used to report additional lesions beyond the first, the potential inclusion of a localization device at the same encounter, and implications for claim reporting and service lines.

The analysis provides national benchmarks and policy context where available, highlights payer coverage patterns, and clarifies the clinical scenarios in which MR-guided percutaneous breast biopsy is selected. Data not provided in the input are noted explicitly as unavailable.